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It is commonly thought that traditional risk factors, namely,
hypertension, high cholesterol, cigarette smoking, and
physical inactivity, can at best explain only 50% of the
variation in mortality in coronary heart disease (1), although
this has recently been called into question (2). This apparent
explanatory lacuna has prompted many investigators to seek
additional, particularly behavioral, risk factors. Early inquiry
focused on type A behavior and hostility, but more recently
attention has shifted to mood states, such as depression and
anxiety.
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Symptoms of depression and anxiety are prevalent among
patients after myocardial infarction (MI), with rates ranging
from 17% to 37% (3–9) and 24% to 31% (3,4,6,9–12),
respectively. In addition, such symptoms often persist over
the ensuing months (13,14), adversely affecting a patient’s
quality of life (6,9) and increasing their cardiac morbidity
(3,5,15). Furthermore, symptoms of depression after MI
have been associated with an increased risk of recurrent
cardiac events (3,8,10,11) and an increase in short-term
cardiac and/or all-cause mortality (18 months) (3–
5,7,10,12).
The apparently independent association reported be-
tween mortality and depression has helped inspire three
randomized controlled trials, two pharmacologic (Myocar-
dial INfarction and Depression-Intervention Trial, or
MIND-IT [16], and Setraline Antidepressant Heart Attack
Randomized Trial, or SADHART [17]) and one cognitive-
behavioral, supplemented where necessary with antidepres-
sant medication (ENhancing Recovery In Coronary Heart
Disease, or ENRICHD [18]). These trials were designed to
afford an experimental test of the proposition that depres-
sion after MI was causally linked to clinical prognosis
(recurrent events and death). In MIND-IT (16), an ongo-
ing trial, patients with a post-MI depressive episode were
randomized to receive antidepressant medication or usual
care. Unfortunately, the results of this trial are not yet
available. In ENRICHD (18), substantial numbers of MI
patients with evidence of current depression and/or a history
of depression were allocated to either cognitive-behavioral
therapy or usual care. Whereas the intervention reduced
depression at six months, it had no effect on re-infarction or
mortality (19). A not-insignificant number of the interven-
tion patients, 249 (27%), received adjunctive antidepressant
medication. It is perhaps hardly surprising, then, that
analogous outcomes emerged from a much smaller study,
that is, SADHART (17), of pharmacotherapy in this
context. Although treatment with antidepressants reduced
depression, it did not effect left ventricular ejection fraction
(LVEF), ventricular arrhythmias, or electrocardiogram pro-
file (19). It is worth noting that since the launch of these
trials, a number of observational studies have failed to find
an independent association between symptoms of depres-
sion (6,9,15,20,21) and/or anxiety (6,9) and short-term
mortality after MI.
Compared with the extensive literature on depression and
MI, relatively little research has been conducted investigat-
ing the effects of anxiety post-MI. This is surprising given
that anxiety and depression are highly comorbid disorders
(22). To date, only five prospective studies had examined
anxiety in this context, and their results are far from
consistent (3,6,9,10,12). One reported a positive association
(10) between symptoms of anxiety and increased risk of
mortality post-MI, whereas three found no association
(6,9,12), and the other presented mixed findings, with
anxiety predicting cardiac events but not mortality (3).
Given the relative paucity of research on anxiety and
prognosis after MI, the observational study by Strik et al.
(15) reported in this issue of the Journal is particularly
welcome.
Why are there differences in study outcomes exploring
the link(s) between MI and depression/anxiety? The incon-
sistency in previous findings may be due, in part, to the
dissimilar MI populations studied and methodologic differ-
ences. The sample populations varied markedly, with highly
selected MI populations, namely patients with arrhythmias
(12) and those with significant left ventricular dysfunction
(10), which may have heightened their mortality risk.
Studies also vary markedly in the time delay between the
occurrence of MI and measurement of anxiety symptoms.
The variety of diagnostic instruments and standardized
questionnaires used may also have contributed to the vari-
ations in the outcomes of studies. Furthermore, small
samples sizes and the failure to report multivariate analyses
controlling for other risk factors cast doubts on the out-
comes of some studies (10). With such variations in popu-
lation measurement, design, and statistical control, it might
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be expected that results would vary considerably. Because
the studies measuring anxiety in this context also measured
depression, the same can be and has been said about
variations in the results regarding depression and clinical
outcome (23).
However, aside from these methodologic variations, there
is one other fairly consistent distinction between prospective
observational studies failing to find and those reporting an
association between anxiety and/or depression on the one
hand and cardiac events and mortality after the index MI on
the other. This has to do with the issue of disease severity
and its relationship with anxiety and depression. For exam-
ple, in the two most recent studies to report null findings,
symptoms of anxiety and depression measured in-hospital
were not significantly associated with indices of disease
severity and mortality (6,9). In our own study (6), symptoms
of depression and anxiety were not related to our main
indices of disease severity (Peel Index score and Killip class)
and, with the exception of diabetes, neither were they
associated with conventional cardiac disease risk factors. In
the other study (9), distressed and non-distressed patients
did not differ in terms of the sorts of cardiologic variables
(previous history of MI and relevant surgical procedures)
often connected to prognosis. Although indices of disease
severity predicted clinical prognosis in these studies, anxiety
and depression, as indicated, did not.
Anxiety and depression would appear to predict clinical
prognosis after MI mainly in studies that have either not
controlled for cardiac disease severity (10) or in which
disease severity is significantly correlated with depression or
anxiety (3–5,7,8). Others have noted that one of the main
obstacles to attributing a causal role to mood status in
clinical prognosis after MI is the potential confounding of
mood after MI with disease severity (24). In many of the
studies that have reported a positive association between
mood and mortality, the relationship between mood state
and mortality was no longer statistically significant after
adjustment for disease severity (7,8,20,21). However, in one
very influential study (3–5), the association between depres-
sion and mortality survived correction for indices of disease
severity, such as Killip class, even though mood status and
Killip class were related. Furthermore, in the study reported
by Strik et al. (15), symptoms of anxiety and depression
were not significantly related to traditional coronary heart
disease risk factors in univariate analyses, with the exception
of smoking, nor with LVEF. However, both depression and
anxiety predicted subsequent cardiac events, although only
the latter survived in a multivariate analysis that tested both
depression and anxiety.
Let us consider these two apparent exceptions in turn
(3–5,15). First, let us examine the most apparently compel-
ling evidence available that the association between mood
and mortality survives adjustment for disease severity (3–5).
The inference that some exposure or characteristic consti-
tutes an independent risk factor for some health outcome is
usually based on multivariate analysis in which a statistically
significant bivariate association between the exposure or
characteristic and the health outcome remains after adjust-
ment for potential confounding variables. However, decla-
rations of independence on this basis may be premature
(25–27). The ability of multivariate statistical models to
determine independence depends on the accuracy of mea-
surement of the potentially confounding variables; any
inaccuracy will inevitably lead to underestimation of their
true impact (25–27). In other words, as Davey Smith and
Phillips (28) pointed out: “it can appear that a risk factor is
related to disease after the adjustment for confounding
factors, but this residual relationship only exists because of
under-adjustment for these confounding factors.” The in-
dices of disease severity used in observational studies in this
area have been various and all are imperfect. Accordingly,
characteristics such as mood can appear to have an inde-
pendent association with mortality, but this could arise as a
consequence of the confounding of mood with disease
severity and the imprecise measurement of disease severity.
Let us now examine the result reported in Strik et al. (15).
Here, the association between anxiety and depression and
subsequent cardiac events also survived correction for dis-
ease severity, indexed in this case by LVEF. This is hardly
surprising, given that LVEF did not correlate with mood.
However, LVEF per se is an imprecise index of overall
disease severity because a great many other factors (in-
cluding blood pressure, renal function, the presence of
arrhythmias and heart failure) are all relevant in defining
how “sick” a patient is. It remains possible that control-
ling for some of these other indices of severity may have
abolished the association between mood and subsequent
cardiac events.
The balance of evidence and argument suggests that it is
right for one to be skeptical about a causal link between
mood, whether anxiety or depression, after MI and subse-
quent cardiac events and mortality. Nevertheless, the high
prevalence and persistence of symptoms of anxiety and
depression over the first 12 months after MI (13) provides
a sufficiently strong argument per se that much more
attention needs to be directed to the emotional status of
recovering MI patients. Although “hard” clinical end points
will necessarily remain a key consideration in managing
cardiac disease, cardiology is beginning to embrace other
outcomes, such as quality of life. Research has shown that
depression and anxiety measured at the time of MI are
predictive of quality of life 12 months later (6,9). A poor
emotional state in MI patients may also comprise compli-
ance with medical advice (29) and participation in cardiac
rehabilitation (30,31), as well as increasing health care
consumption (15). It is for these reasons that we have
argued recently (23) that treating symptoms of anxiety and
depression in MI patients is an abiding imperative. It will
remain so even if there is no causal link between such
symptoms and subsequent cardiac events and mortality.
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